Featured Research

from universities, journals, and other organizations

Bacterial Mimic Under Study As Cancer Vaccine May Also Help Protect Tumors

Date:
November 7, 2005
Source:
Medical College of Georgia
Summary:
A bacterial mimic under study as a cancer vaccine because it signals the immune system to attack may also help some tumors hide, researchers have found. Inside the body, the reagent – CpG oligodeoxynucleotides or CpG-ODNs – alerts the body’s natural warning system to an invader.

Dr. Andrew L. Mellor is an immunologist and director of the Medical College of Georgia Immunotherapy Center.
Credit: Photo by Phil Jones

A bacterial mimic under study as a cancer vaccine because it signals the immune system to attack may also help some tumors hide, researchers have found.

Inside the body, the reagent – CpG oligodeoxynucleotides or CpG-ODNs – alerts the body’s natural warning system to an invader, says Dr. Andrew L. Mellor, immunologist and director of the Medical College of Georgia Immunotherapy Center.

In an animal model, Dr. Mellor and his colleagues have found CpG-ODNs also can trigger a mechanism that may have helped the tumor survive in the first place: expression of an enzyme that enables it to hide from the immune system.

“What we have found is the ability to ring the alarm bell is a double-edged sword,” says Dr. Mellor of new findings reported as a Cutting Edge article in the Nov. 1 issue of The Journal of Immunology. “The immunology community believes that the only thing these bacterial mimics do through the Toll-like receptors is ring the alarm bells to stimulate T cells to action. We are saying that if you deliver them in a certain way, they will also signal induction of the mechanism we have been working on which does exactly the opposite.”

The mechanism is an enzyme, indoleomine 2,3-dioxegenase, that locally suppresses the immune response. MCG researchers reported in Science in 1998 that one way fetuses avoid rejection by the mother’s immune system is expressing IDO, which degrades tryptophan, an amino acid essential to survival of T-cells, orchestrators of immune response. Since then, the researchers have found that tumors and some infectious agents, such as HIV, use this mechanism to escape the immune system.

In fact, Dr. David Munn, pediatric hematologist-oncologist, study co-author and Dr. Mellor’s longtime research partner, is working with the National Institutes of Health on toxicity studies of an IDO inhibitor the researchers use in the lab with the goal of moving toward clinical studies of its potential to help cancer patients fight resistant tumors.

Dr. Munn says the treatment would likely be an adjunct to existing treatments, such as chemotherapy. Their newest study indicates the IDO inhibitor may also be a good companion treatment for the cancer vaccine that utilizes CpG-ODNs, says Dr. Mellor, a Georgia Research Alliance Eminent Scholar in Molecular Immunogentics.

CpG-ODNs work by binding to Toll-like receptors, found on a number of different immune cells, including the pervasive dendritic cells that direct T cells. “About a decade ago, it was discovered that what these Toll-like receptors have evolved to do is recognize what we immunologists call danger,” says Dr. Mellor. “Danger comes in many forms, but the way to think about this is that bacteria and pathogens will produce new structures which are seen as dangerous by the immune system using these receptors. This is absolutely the way you should respond to danger. You should get the T cells involved.”

But the double-edged sword comes in because some dendritic cells also can express IDO and turn T cells off, the MCG researchers say.

One of the many directions their research is taking is exploring the role of IDO in regulatory T cells, that also have the ability to shut down the immune response, ideally to keep it from attacking the body’s own tissue in autoimmune diseases such as arthritis.

“Regulatory T cells are really important to consider in many disease situations,” says Dr. Mellor. “In the context of cancer, it’s known that tumors induce regulatory T cells, which is in the interest of the tumor, not the patient. The patient wants to get rid of regulatory T cells in this circumstance because they are not helping the immune system to destroy the tumor. IDO is working in the same direction: it’s helping to protect the tumor from attack.”

One of their questions is whether IDO is helping generate regulatory T cells.

If the answer turns out to be yes, it will provide evidence that IDO is not just one way tumors protect themselves, but an essential factor in this unfortunate ability, Dr. Mellor says.

Co-authors on the current study include Dr. Munn; Dr. Phillip R. Chandler, principal research scientist, MCG Immunotherapy Center; Dr. Babak Baban, research scientist, MCG Immunotherapy Center; and Anna Manlapat and David J. Kahler, graduate students in Dr. Mellor’s lab.

Coley Pharmaceutical Group, Inc., developers of the cancer vaccine, supplied the MCG researchers with CpG-ODN and advice. The work was funded by the National Institutes of Health.


Story Source:

The above story is based on materials provided by Medical College of Georgia. Note: Materials may be edited for content and length.


Cite This Page:

Medical College of Georgia. "Bacterial Mimic Under Study As Cancer Vaccine May Also Help Protect Tumors." ScienceDaily. ScienceDaily, 7 November 2005. <www.sciencedaily.com/releases/2005/11/051107085421.htm>.
Medical College of Georgia. (2005, November 7). Bacterial Mimic Under Study As Cancer Vaccine May Also Help Protect Tumors. ScienceDaily. Retrieved October 23, 2014 from www.sciencedaily.com/releases/2005/11/051107085421.htm
Medical College of Georgia. "Bacterial Mimic Under Study As Cancer Vaccine May Also Help Protect Tumors." ScienceDaily. www.sciencedaily.com/releases/2005/11/051107085421.htm (accessed October 23, 2014).

Share This



More Health & Medicine News

Thursday, October 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Fears Keep Guinea Hospitals Empty

Ebola Fears Keep Guinea Hospitals Empty

AP (Oct. 23, 2014) Fears of Ebola are keeping doctors and patients alike away from hospitals in the West African nation of Guinea. (Oct. 23) Video provided by AP
Powered by NewsLook.com
Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) Is your child ready? Video provided by Working Mother
Powered by NewsLook.com
U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

Newsy (Oct. 22, 2014) Now that the U.S. is restricting travel from West Africa, some are dropping questions about a travel ban and instead asking about visa bans. Video provided by Newsy
Powered by NewsLook.com
More People Diagnosed With TB In 2013, But There's Good News

More People Diagnosed With TB In 2013, But There's Good News

Newsy (Oct. 22, 2014) The World Health Organizations says TB numbers rose in 2013, but it's partly due to better detection and more survivors. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins